CANCER RESEARCH UK (04325234) is a pri/lbg/nsc (private, limited by guarantee, no share capital, use of 'limited' exemption) registered in LONDON, incorporated in 2001. The company operates in the other human health activities sector. With 227 data signals collected from 23 government and public sources, CANCER RESEARCH UK has one of the more comprehensive data profiles in our database. Risk assessment: 86/100 ("robust"), reflecting a strong compliance and financial profile. The company has 1 outstanding mortgage charge registered with Companies House.
Cancer Research UK is an active charity incorporated in 2001 located in London, operating within the other human health activities industry. As the world's leading cancer charity, it is dedicated to beating cancer by carrying out research into more than 200 types of cancer to save and improve lives.
Extensive data coverage from 23 government and public sources. Risk score of 86 indicates a strong compliance profile.
CANCER RESEARCH UK is 1 of 11,939 other human health activities companies in LONDON, out of 75,183 active companies in this sector nationally (92,454 including dissolved).
CANCER RESEARCH UK is listed as the proprietor of 477 properties in the HM Land Registry.
Properties are located in East Anglia, East Midlands, Greater London, North, North West, South East, South West, Wales, West Midlands, Yorks And Humber.
CANCER RESEARCH UK has been awarded 2 government contracts with a combined value of £31K.
The most recent contract was with UK SHARED BUSINESS SERVICES LIMITED (11 Mar 2022).
CANCER RESEARCH UK pays invoices in an average of 25 days. 60% are paid within 30 days.
This company profile is built from 20 official data sources: 360Giving, Ch Officers, Charity Commission, Companies House, Contracts Finder, DWP, Environment Agency, FSA Register, Food Standards Agency, GLEIF, Gambling Commission, Gateway to Research, Gender Pay Gap Service, HM Land Registry, ICO, Modern Slavery Registry, OpenSanctions, Payment Practices, Valuation Office, WHOIS.
Cancer Research UK is an active charity incorporated in 2001 located in London, operating within the other human health activities industry.
Current directors include MR ROBERT JAMES CAMPBELL EASTON, PROFESSOR PAMELA RENATE KEARNS, PROFESSOR DOREEN ANN CANTRELL and 2 more.
CANCER RESEARCH UK is registered in LONDON, United Kingdom.
CANCER RESEARCH UK operates under SIC code 86900 — Other human health activities.
CANCER RESEARCH UK has a risk score of 86 out of 100, classified as "Robust". This score is calculated from 227 data signals across 23 government sources.
The next accounts for CANCER RESEARCH UK are due on 31 Dec 2026.
CANCER RESEARCH UK offers Cancer research funding, Trusted cancer information, Cancer chat forum, Screening checker, Fundraising resources.
Yes, CANCER RESEARCH UK is listed as the proprietor of 477 properties in the HM Land Registry, located in East Anglia, East Midlands, Greater London, North, North West, South East, South West, Wales, West Midlands, Yorks And Humber.
Yes, CANCER RESEARCH UK has been awarded 2 government contracts with a combined value of £31K.
The dissolution rate for the other human health activities sector in the UK is 11.7%. The average company age in this sector is 7.2 years.
CANCER RESEARCH UK is currently listed as "Active" on Companies House, indicating it is still a registered company. An "Active" status means the company has not been dissolved, struck off, or entered into liquidation.
CANCER RESEARCH UK is registered as a PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption), which is a registered UK business entity.
CANCER RESEARCH UK was incorporated on 20 Nov 2001, making it 25 years old. The company remains active and in good standing.
CANCER RESEARCH UK is classified under SIC code 86900 (Other human health activities). The Standard Industrial Classification system is used by the UK government to categorise businesses by their primary economic activity.
We track 227 data signals from 23 official government sources for CANCER RESEARCH UK.